• Sectors we work in banner(2)

    Quick Reads

The ongoing fight against fakes

min read

When counterfeit goods are mentioned, initial thoughts may be of luxury items such as handbags copied in a far cheaper and more accessible form. Hidden behind such goods is the harm done to rights holders, who have invested time and money developing and producing a product, and the organised crime and downstream harm caused by such counterfeit items. However, other products are also counterfeited and the impact to the consumer can be more immediate and dangerous – electrical goods and pharmaceuticals are two categories that are also frequently copied.

EUROPOL recently coordinated the fourth edition of Operation SHIELD, a global effort to tackle fake pharmaceuticals.  The operation saw 1,284 individuals charged and took fake medicines worth EUR 64 million off EU markets.

The sale of fake pharmaceuticals, and illegal trafficking of pharmaceuticals, continues to be a growing issue and is a significant public health problem.

The Internet remains an enticing outlet for suppliers of counterfeit goods and social media is a current popular forum for selling counterfeit and illegally sold medicines. Of key importance is educating users of social media, particularly younger generations, on the significant safety risks associated with sourcing pharmaceuticals outside the legitimate supply chain. As consumers, it is key that we question what the item is and where it has come from.

Brand owners should seek to protect and enforce their trade mark rights to help curb the proliferation of counterfeit products worldwide and protect consumers. 

The EUROPOL press release makes for impressive reading but the fight against counterfeiters is ongoing. Vigilance by consumers and brand owners, and protection of important intellectual property, are key.

 

Medicines are often counterfeited in underground laboratories without any regulation or safety measures in place. Counterfeit products created under such circumstances do not produce the desired effect; in the best case scenario the patient remains untreated, however such products can cause serious health issues or be potentially lethal.

Our thinking

  • The Playbook to Superscale: Hacks 1-3

    Events

  • From Prime Time to Match Day: Engaging the Female Audience

    Events

  • 10 ways the new APR/BPR rules affect estate administration

    Mary Perham

    Insights

    min read
  • ITV News interviews Ben Smith about a parliamentary debate around statutory menstrual leave

    Ben Smith

    In the Press

    min read
  • Clarification given by the Court of Appeal on rights of first refusal under the Landlord and Tenant Act 1987

    Natalie Deuchar

    Insights

    min read
  • Corporate restructuring: Preparing for Future Challenges

    Shirley Fu

    Insights

    min read
  • Choosing the Right PISCES Platform for Private Company Liquidity

    Greg Stonefield

    Insights

    min read
  • How to construe contentious trusts - lessons from recent cases

    Sarah Moore

    Insights

    min read
  • Q&A: Modifying Restrictive Covenants

    Chandni Pandya

    Insights

    min read
  • RICS Property Journal features Chandni Pandya and Georgina Muskett on service charges for live/work units

    Chandni Pandya

    In the Press

    min read
  • Grid Connections, Environmental Assessment and the DCO Process – What is the effect of the Raeshaw Farms judgement?

    Kevin Gibbs

    Insights

    min read
  • Construction News and Facilities Management Now quote William Turner, Elizabeth Hughes, and Alexander Hemmings on new Construction Industry Scheme rules for supply chain fraud

    Elizabeth Hughes

    In the Press

    min read
  • Eddie Richards and Sadie Pitman write for Logistics Business on the UK's readiness for an electric vehicle revolution

    Sadie Pitman

    In the Press

    min read
  • Chiara Muston comments in People Management on 'empty time' and the gig economy

    Chiara Muston

    In the Press

    min read
  • Q&A: Boundary Issues

    Emma Preece

    Insights

    min read
  • Remedy and Leverage: Addressing Human Rights Risks in Corporate Supply Chains

    Kerry Stares

    Insights

    min read
  • How is the UK Construction Industry Impacted by Modern Slavery?

    Henry Dalton

    Insights

    min read
  • Martyn’s Law: What Historic Houses Need to Know

    Naomi Nettleton

    Insights

    min read
  • Application for modification of restrictive covenant fails on “worst case” scenario

    Georgina Muskett

    Insights

    min read
  • Social risks in the supply chain – from due diligence to resilience: Corporate human rights due diligence – a snapshot of the law in EU/UK

    Kerry Stares

    Podcasts

Back to top